Search results
Showing 346 to 360 of 467 results for %s
Read NICE's statement on modern slavery and human trafficking
Study NICE and LSE's Executive MSc Healthcare Decision-Making
Study NICE and LSE's Executive MSc Healthcare Decision-Making
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.
Ibrutinib for treating Waldenstrom's macroglobulinaemia (TA795)
Evidence-based recommendations on ibrutinib (Imbruvica) for Waldenstrom’s macroglobulinaemia in adults who have had at least 1 previous therapy.
NICE's impact on preventing or delaying the onset of dementia
NICE has developed a medtech innovation briefing (MIB) on digital technologies for the detection of melanoma .
details of the evidence and the committee's discussion are in evidence review S: previous caesarean section . Source guidance details...
NICE'S quick guide to developing a positive working culture for supporting disabled children and young people with severe complex needs
Padeliporfin for untreated localised prostate cancer (TA546)
Evidence-based recommendations on padeliporfin (Tookad) for untreated, unilateral, low-risk prostate cancer in adults.
Find out more about NICE's new proportionate approach to technology appraisals
Bosutinib for previously treated chronic myeloid leukaemia (TA401)
Evidence-based recommendations on bosutinib (Bosulif) for previously reated chronic myeloid leukaemia in adults.
NICE has developed a medtech innovation briefing (MIB) on WoundExpress to manage lower leg wounds .
This guideline covers the short-term management of violence and aggression in adults (aged 18 and over), young people (aged 13 to 17) and children (aged 12 and under). It is relevant for mental health, health and community settings. The guideline aims to safeguard both staff and people who use services by helping to prevent violent situations and providing guidance to manage them safely when they occur.
i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department (MIB38)
NICE has developed a medtech innovation briefing (MIB) on i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department
NICE's impact on managing long-term conditions in children in the community